BIOMAT Database Logo BIOMAT Database Logo

Influence of rapid correction of metabolic acidosis on serum osteocalcin level in chronic renal failure. 1994

Y F Lin, and S D Shieh, and L K Diang, and S H Lin, and S H Chyr, and B L Li, and K C Lu
Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China.

Metabolic acidosis induces a combination of inhibited osteoblastic and stimulated osteoclastic activity. To determine the role of alkali therapy in osteoblast function in chronic renal failure, serum bone isoenzyme of alkaline phosphatase (BAP) and osteocalcin were assessed before and after bicarbonate infusion. Eighteen patients with mild to moderate metabolic acidosis, none of whom had received dialysis therapy, were enrolled in this study. Metabolic acidosis was corrected by continuous bicarbonate infusion while plasma ionized calcium was monitored at 5 min intervals and held at the preinfusion level by calcium solution infusion during the entire procedure. The end-point of the study was reached when the plasma bicarbonate was approximately 24 mmol/l or pH was approximately 7.4 and plasma ionized calcium was clamped at the preinfusion level with only a 0.01 mmol/l fluctuation. The plasma pH (7.31 +/- 0.04 vs. 7.40 +/- 0.03, P < 0.001), bicarbonate (18.46 +/- 2.49 vs. 23.66 +/- 2.72 mmol/l, P < 0.001), serum total calcium, and osteocalcin (15.61 +/- 6.45 vs. 18.79 +/- 6.71 mg/l, P < 0.05) levels were significantly increased, whereas serum concentrations of alkaline phosphatase and albumin levels were significantly decreased after bicarbonate infusion. The serum BAP (1.85 +/- 1.29 vs. 1.79 +/- 1.18 mukat/l, P = 0.252), and inorganic phosphorus levels showed no significant differences before and after bicarbonate infusion. These results demonstrate that rapid correction of metabolic acidosis improves osteoblast function and may underline the importance of maintaining normal acid-base homeostasis in chronic renal failure.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010006 Osteoblasts Bone-forming cells which secrete an EXTRACELLULAR MATRIX. HYDROXYAPATITE crystals are then deposited into the matrix to form bone. Osteoblast
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D012080 Chronic Kidney Disease-Mineral and Bone Disorder Decalcification of bone or abnormal bone development due to chronic KIDNEY DISEASES, in which 1,25-DIHYDROXYVITAMIN D3 synthesis by the kidneys is impaired, leading to reduced negative feedback on PARATHYROID HORMONE. The resulting SECONDARY HYPERPARATHYROIDISM eventually leads to bone disorders. Renal Osteodystrophy,Renal Rickets,Rickets, Renal,CKD-MBD,Osteodystrophy, Renal,Chronic Kidney Disease Mineral and Bone Disorder,Osteodystrophies, Renal,Renal Osteodystrophies
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Y F Lin, and S D Shieh, and L K Diang, and S H Lin, and S H Chyr, and B L Li, and K C Lu
The influence of salt intake on the metabolic acidosis of chronic renal failure;.
August 1975, The Journal of clinical investigation,
Y F Lin, and S D Shieh, and L K Diang, and S H Lin, and S H Chyr, and B L Li, and K C Lu
Serum osteocalcin in children with chronic renal failure.
January 1997, Nephron,
Y F Lin, and S D Shieh, and L K Diang, and S H Lin, and S H Chyr, and B L Li, and K C Lu
Serum ionized calcium in dogs with chronic renal failure and metabolic acidosis.
December 2006, Veterinary clinical pathology,
Y F Lin, and S D Shieh, and L K Diang, and S H Lin, and S H Chyr, and B L Li, and K C Lu
Acute correction of metabolic acidosis increases serum procollagen type I carboxyterminal propeptide in patients with chronic renal failure.
November 2001, Journal of the Formosan Medical Association = Taiwan yi zhi,
Y F Lin, and S D Shieh, and L K Diang, and S H Lin, and S H Chyr, and B L Li, and K C Lu
Changes in serum leptin levels in chronic renal failure patients with metabolic acidosis.
October 2001, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation,
Y F Lin, and S D Shieh, and L K Diang, and S H Lin, and S H Chyr, and B L Li, and K C Lu
Effect of the correction of metabolic acidosis on nutritional status in elderly patients with chronic renal failure.
October 2002, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation,
Y F Lin, and S D Shieh, and L K Diang, and S H Lin, and S H Chyr, and B L Li, and K C Lu
Zinc bone loss in chronic renal failure and chronic metabolic acidosis.
January 1992, Biological trace element research,
Y F Lin, and S D Shieh, and L K Diang, and S H Lin, and S H Chyr, and B L Li, and K C Lu
[Serum prolactin level in chronic renal failure].
August 1978, Nihon rinsho. Japanese journal of clinical medicine,
Y F Lin, and S D Shieh, and L K Diang, and S H Lin, and S H Chyr, and B L Li, and K C Lu
The metabolic acidosis of chronic renal failure: pathophysiology and treatment.
January 1992, Contributions to nephrology,
Y F Lin, and S D Shieh, and L K Diang, and S H Lin, and S H Chyr, and B L Li, and K C Lu
Influence of acute hyponatremia on renal ammoniagenesis in dogs with chronic metabolic acidosis.
February 1990, The American journal of physiology,
Copied contents to your clipboard!